Background {#Sec1}
==========

Cancer is considered as a serious and potentially life-threatening illness, and cancer patients have to experience a constellation of challenges, including cancer diagnosis, side effects of medical treatment, sleep disturbance \[[@CR1]\], poor adjustment \[[@CR2]\], coping strategies \[[@CR3]\], emotional distress \[[@CR4]\] and problems arising in the family \[[@CR5]\]. Therefore, it is well acknowledged that adults diagnosed with cancer are vulnerable to depression and anxiety. In developed countries, such as United States and UK, systemic reviews have indicated that depression and anxiety were two of the common psychological distress in cancer patients \[[@CR6]--[@CR9]\]. Our previous meta-analysis also found that the prevalence of depression (54.90% vs. 17.50%) and anxiety (49.69% vs. 18.37%) were significantly higher in Chinese adults with cancer compared with those without \[[@CR10]\]. More seriously, the unrecognized and untreated depression and anxiety could not only lead to difficulty with symptom control, poor compliance with treatment and prolonged recovery time, but also the increased impairment of immune response and impaired quality of life \[[@CR11]--[@CR13]\].

The evidence mentioned above, combined with different national contexts, has led to the increasing interest in psychological interventions in different countries, and cancer patients themselves also reported the need of professional psycho-oncological support \[[@CR14]\]. A number of systematic reviews (qualitative and quantitative) have focused on the effectiveness of psychological interventions on depression and anxiety, and psychological interventions, to some extent, have been shown to be effective in reducing depression/anxiety in cancer patients. However, a clear conclusion has not been reached, and the controversy over the effectiveness of psychological interventions still continues. Qualitative review conducted by Newell et al. concluded that no intervention strategy could be recommended for managing depression \[[@CR15]\], but Barsevick et al. claimed that psychoeducational interventions were effective for reducing depressive symptoms in cancer patients \[[@CR16]\]. Meanwhile, some meta-analyses have provided effect sizes ranging from insignificance \[[@CR17], [@CR18]\] to small-medium \[[@CR19], [@CR20]\] and small-medium to large \[[@CR21]\]. In addition, systematic reviews often focused on either specific type of cancer patients \[[@CR18]\] or specific type of intervention \[[@CR22], [@CR23]\], which makes it difficult to draw clear conclusions. Recently, Faller et al. pointed out these issues and conducted a comprehensive meta-analysis of 198 controlled studies. The results indicated that psycho-oncologic interventions were effective for depression (Cohen's d = 0.33, 95% CI = 0.25-0.41) and anxiety (Cohen's d = 0.38, 95% CI = 0.29-0.46) \[[@CR20]\].

Although a number of systematic reviews have been conducted to evaluate the effects of psychological interventions on depression/anxiety in adults with cancer, the effects of psychological interventions on depression/anxiety in Chinese cancer patients have still yet not been examined. Conducting such meta-analysis is vitally important for the following reasons. The first reason is attributed to the number of cancer patients in China. The latest data revealed that China had the world's largest cancer population (new cases and deaths) in 2012. The numbers of new cases and deaths were 3.07 million (21.8% of world total) and 2.20 million (26.9%) \[[@CR24]\]. The second reason is due to the high prevalence of depression and anxiety in Chinese adults with cancer. Compared with the prevalence of depression/anxiety among cancer patients in developed countries, our previous meta-analysis found that the prevalence of depression (54.90%) and anxiety (49.69%) was at a high level in China \[[@CR10]\]. Third, although the field of psycho-oncology and its related psychological interventions are relatively young in China, intervention studies and narrative reviews are no longer rare. However, there has not been a comprehensive meta-analysis to assess the effects of psychological interventions on depression/anxiety in Chinese adults with cancer. Forth, because most of the results of these intervention studies were published in Chinese journals, they are usually not easily accessed by other countries' researchers. Finally, a number of Chinese studies about depression/anxiety of cancer patients adopted psychological interventions (such as cognitive-behavioral and psychoeducational therapy) originated in Western countries. It is necessary to explore whether the psychological interventions widely used in Western countries are also effective among Chinese adults with cancer. More importantly, from a clinical point of view, it would be of practical importance for clinicians to evaluate whether psychological interventions, in addition to the medication, not only have positive effects on depression and anxiety, but also have the possibility of improving the use efficiency of Chinese clinical resources.

The aim of the present meta-analysis, therefore, was to quantify the effectiveness of psychological interventions for treatment of depression and anxiety reported in randomized controlled trials (RCTs) in Chinese adults with cancer. First, we explored the overall effect size of psychological interventions on depression and anxiety in cancer patients. Second, we examined whether the overall effect size was modified by moderating factors (e.g., intervention type, cancer type, and mean age).

Methods {#Sec2}
=======

Literature search {#Sec3}
-----------------

A systematic search was conducted to identify published literature on the effects of psychological interventions on depression/anxiety in Chinese adults with cancer. The CNKI database (China National Knowledge Infrastructure), Wanfang database, Vip database and CBM database (Chinese Biomedical Literature Database), which are the four most comprehensive Chinese academic databases, were searched from their inception until January 2014. We used 'depression or depressive disorders or depressive symptoms' and 'anxiety or anxiety disorder or anxiety symptoms' and 'cancer or oncology or malignant neoplasm or malignant tumor' combined with 'psychological intervention or psychological treatment or psychotherapy' as search themes in the article titles, abstracts and keywords. The reference lists of relevant articles obtained were also screened.

In order to expand searches, PubMed and Web of Science (SCIE) were searched from their inception until January 2014 without language restrictions, and an internet search was also used (e.g., <http://www.google.com>). The search strategy was: (psychotherapy \[MeSH Terms\] OR psychotherapy \[Title/Abstract\] OR psychological therapy \[Title/Abstract\] OR psychiatric counseling \[Title/Abstract\] OR psychological intervention \[Title/Abstract\] OR psychological treatment \[Title/Abstract\]) AND (neoplasms \[MeSH Terms\] OR cancer \[Title/Abstract\] OR neoplasms \[Title/Abstract\] OR oncology \[Title/Abstract\]) AND (China \[MeSH Terms\] OR China or Mainland China \[Title/Abstract\]) AND (depression \[MeSH Terms\] OR depressive disorder \[MeSH Terms\] OR depression \[Title/Abstract\] OR depressive disorder \[Title/Abstract\] OR depressive symptoms \[Title/Abstract\] OR anxiety \[MeSH Terms\] OR anxiety disorders \[MeSH Terms\] OR anxiety \[Title/Abstract\] OR anxiety disorders \[Title/Abstract\] OR anxiety symptoms \[Title/Abstract\]).

The screening of the abstracts/titles and full-text articles were performed twice by three authors (YLY, GYS, GCL) independently to reduce reviewer bias and errors.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

We included all studies in which: (1) the subjects were aged 16 or older; (2) RCTs were eligible, including experimental group and control group; (3) the subjects were patients diagnosed with cancer; (4) studies were included to those involving more than 30 adults with cancer; (5) a psychological intervention in experimental group was compared to a control group; (6) depression and anxiety were evaluated by well-validated measures, such as clinical diagnosis and self-report questionnaires that previous studies have established the reliability and validity of them as a measure of depression/anxiety at home and abroad; (7) the subjects were from Mainland China (Hong Kong, Taiwan and Macao were excluded due to the long-term influence of foreign culture). We excluded studies in which: (1) the description of psychological interventions was not set forth so clearly in the Method section that other researchers could not duplicate or refer to such studies to conduct psychological interventions; (2) studies in which insufficient data were available to calculate effect sizes were excluded; (3) studies including non-psychological interventions, such as physiotherapy, physical training, and medicine interventions were excluded; (4) Hospice and terminal home care were excluded because they might be distinct from psychological interventions; (5) studies using dimension scores to evaluate depression/anxiety (e.g., depression and anxiety dimension scores of SCL-90) were excluded. Eligibility judgment and data extraction were recorded and carried out independently by two authors (YLY and GYS) in a standardized manner. Any disagreements with them were resolved by discussion and the involvement of another author (LW).

Quality assessment {#Sec5}
------------------

Although many scales are used to evaluate the methodological quality of RCTs, none can provide an adequately and comprehensively reliable assessment \[[@CR25]\]. A systematic review indicated that Jadad scale presented the best validity and reliability evidence compared with other scales \[[@CR25]\], but Jadad scale only including 3 items \[[@CR26]\] may be too simple to well assess quality of RCTs in our meta-analysis. Therefore, the modified Jadad scale for assessing quality of RCTs was adapted for use \[[@CR27]\]. The modified Jadad scale is an eight-item scale designed to assess randomization, blinding, withdrawals/dropouts, inclusion/exclusion criteria, adverse effects, and statistical analysis. In this meta-analysis, blinding (2 points) and adverse effects (1 point) were excluded, because blinding is often not feasible for trials of psychological interventions, and psychological interventions usually has few negative side effects. As a result, the score for each study can range from 0 (lowest quality) to 5 (highest quality).We defined three categories: the study was considered to have high quality (low risk of bias) if it scored 4 points or above, studies that scored 1 point or below were categorized as having low quality (high risk of bias), studies that scored 2 points or 3 points were considered as having medium quality (moderate risk of bias). Any disagreements with authors (GCL and SMW) were resolved by discussion and the involvement of another author (LW).

Data extraction {#Sec6}
---------------

A standardized data extraction scheme was developed and pilot tested on 5 included studies. For all studies, two authors independently extracted data (DSH and SMW). Disagreements were resolved by discussion. In situations where the coder was unsure, one of the authors was consulted until consensus was reached.

Data extracted from the present study included author name, year of publication, age range and mean age, simple size, outcomes (depression and anxiety) and assessment instruments (clinical diagnosis/self-report), selection of participants by the clear signs of depression/anxiety, cancer type, cancer stage, intervention type (cognitive-behavioral interventions (CBT), patients education (PE), relaxation/imagery, social/family support, music therapy, nursing intervention, other), professionalism of therapists (e.g., nurse, doctor, and psychologist), intervention format (individual, group, family), information about treatments and timing of assessment, and mean and standard deviation (SD) of each study.

Among these types of interventions, the seven categories were defined as follows. CBT included cognitive, cognitive-behavioral, and behavioral methods focused on changing specific thoughts or behaviors or on learning specific coping skills. PE (or called information and counseling) included interventions primarily providing health education (procedural or medical information), coping skills training, stress management, and psychological support. If interventions mainly focused on coping skills or psychological support, these were classified as "CBT" or "social/family support". Relaxation and imagery techniques were any method, process, or activity that helped patients to relax and attain a state of calmness. Social/family support referred to nonprofessionally/professionally guided support groups (social support) or to the patients' family members (family support) that provided mutual help and support (e.g., emotional support, financial support, and the communication of shared experiences). Music therapy referred to an interpersonal process in which the therapist used music and all of its facets (physical, emotional, social, and aesthetic) to help patients to improve or maintain their health, and it should be different from "relaxation/imagery" when conducted as the only intervention. Nursing intervention were the actions undertaken by caregivers (mainly nurse) to adopt nonspecific interventions to further provide a high level of care, such as promoting communication with patients and their families, understanding, encouraging and comforting patients, strengthening nursing care, and providing suitable environment. If interventions aimed at emotional support and emotional release, these were classified as "social/family support" or "relaxation/imagery". Interventions not matching these definitions were classified as "other".

Meta-analysis {#Sec7}
-------------

### Assessment of overall effect size {#Sec8}

We computed the effect size of standardized mean difference (SMD) for each study by subtracting the average post-test score of the control group from that of the experimental group and dividing the result by the pooled standard deviations of the experimental group and control group. Means and standard deviations of depression/anxiety were used for computation of SMD (Cohen's *d*). A SMD of 1 indicates a relatively stronger improvement in experimental group by one standard deviation larger than the mean of the control group. For a certain outcome, only one effect size per study was included. If an experimental-control comparison provided more than one effect size for depression/anxiety, the results were averaged. The pooled random-effects estimates of SMD and 95% confidence intervals (CI) were used as the summary measure of effect. A random effects model was used because it involves the assumption of statistical heterogeneity between studies \[[@CR28]\]. Effect sizes of 0.80 are regarded as large, while effect sizes of 0.50 are moderate, and effect sizes of 0.2 are small \[[@CR29]\]. A two-tailed P value of less than 0.05 was considered to be significant. Overall effects were analyzed using the statistical software Stata v11.0.

### Assessment of heterogeneity {#Sec9}

Heterogeneity was evaluated with the Q statistic and I^2^ statistic. The Q statistic is used to assess whether differences in results are compatible with chance alone. If the P value of Q statistic is above 0.05, it indicates that there is no significant heterogeneity, but the Q statistic is sensitive to the number of studies \[[@CR30]\]. To complement the Q statistics, the I^2^ statistic which denotes the variance among studies as a proportion of the total variance was also calculated and reported, because I^2^ is not sensitive to the number of studies \[[@CR30]\]. Larger values of I^2^ show increasing heterogeneity. An I^2^ of 0% shows no observed heterogeneity, while 25% shows low, 50% moderate, and 75% high levels of heterogeneity \[[@CR31]\].

### Moderator analyses {#Sec10}

When the hypothesis of homogeneity was rejected by the Q statistic and I^2^ statistic, meta-regression (continuous variable) and subgroup analysis (categorical variable) were conducted in order to explore the potential moderating factors for heterogeneity \[[@CR30]\]. In our study, meta-regression and subgroup analysis were conducted for moderating factors, including cancer type, cancer stage (early vs. advanced stage), patients' selection (clear signs of depression/anxiety vs. regardless of depression/anxiety level), patients' age, simple size, quality of study, intervention type (CBT, PE, relaxation/imagery, social/family support, music therapy, nursing intervention, other), intervention format (individual vs. other formats), appropriate randomization (yes/no), the used questionnaires and timing of assessment. Because most of studies in our meta-analysis included more than one type of intervention, intervention type was not considered as a categorical variable, and the sum types of intervention was the indicator of intervention type.

### Assessment of publication bias {#Sec11}

The potential of publication bias of the included studies was first examined by funnel plot symmetry. A funnel plot is a useful graph designed to check the existence of publication bias in meta-analyses. A symmetric funnel shape indicates that publication bias is unlikely, but an asymmetric funnel suggests the possibility of publication bias. However, some authors have argued that visual interpretation of funnel plots is too subjective to be useful \[[@CR32]\]. So Begg's test and Egger's test were further used to more objectively test for its presence (as implemented in Stata v11) \[[@CR33], [@CR34]\].

Cumulative meta-analysis {#Sec12}
------------------------

We explored the evolution of evidence of the effects of psychological interventions on depression and anxiety among Chinese cancer patients over time using cumulative meta-analysis \[[@CR35]\]. Studies were sequentially accumulated by year they first became available (e.g., publication in a journal) to a random-effects model using the "metacum" user-written command in Stata v 11.

Results {#Sec13}
=======

Study selection {#Sec14}
---------------

A flowchart describing the inclusion and exclusion process was presented. As shown in Figure [1](#Fig1){ref-type="fig"}, we identified the possibly eligible articles through CNKI database (n = 585), Wangfang database (n = 575), Vip database (n = 430) and CBM database (n = 542). The titles and abstracts of these articles were respectively studied by the three authors (YLY, GYS and GCL), and the full-text articles without duplicates (n = 738) were selected for further examination. Based on the full-text of these 738 studies, 595 did not meet the inclusion criteria as documented in Figure [1](#Fig1){ref-type="fig"}. In total, 143 studies reporting on 247 experimental-control comparisons (Depression: n = 119; Anxiety: n = 128) were included in the present meta-analysis \[[@CR36]--[@CR178]\].Figure 1**Selection process of studies for the meta-analysis (Chinese databases).** Abbreviations: RCTs, randomized controlled trials; CNKI, China National Knowledge Infrastructure; CBM, Chinese Biomedical Literature Database.

In order to expand searches, we also searched the international databases of PubMed, SCIE (as shown in Figure [2](#Fig2){ref-type="fig"}), and an internet search (e.g., <http://www.google.com>). There were 4 studies from PubMed that met our inclusion criteria through the international databases search \[[@CR179]--[@CR182]\].Figure 2**Selection process of studies for the meta-analysis (international databases).** Abbreviations: RCTs, randomized controlled trials; SCIE, Web of Science. \*Records could not be identified through the original search strategy, and "China \[MeSH\] OR China \[Title/Abstract\] or Mainland China \[Title/Abstract\]" was excluded from the original search strategy.

Characteristics of included studies {#Sec15}
-----------------------------------

Study characteristics were listed in Table [1](#Tab1){ref-type="table"}. The studies of this meta-analysis, including 133 journal articles and 14 dissertations, were published from 2000 to 2013. The studies comprised 14,039 subjects. The mean sample size was 95.5 (median: 80; range: 30--326). Subjects had a mean age of 52.4 years (median: 51.9; range: 39--74). Depression and anxiety were assessed by clinical diagnosis in 16 studies \[[@CR37], [@CR42], [@CR47], [@CR48], [@CR58], [@CR83], [@CR101], [@CR102], [@CR107], [@CR108], [@CR113], [@CR127], [@CR132], [@CR144], [@CR146], [@CR181]\], while that of the other studies was assessed by self-report questionnaires like Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS). For a certain outcome, each study only included one effect size. Only 15% of studies preselected patients according to their clear signs of depression/anxiety. Forty-six percent included mixed cancer diagnoses, and 15% included breast cancer and gynaecological cancer, respectively. Seventeen percent of studies included advanced cancer patients, and 6% included early cancer patients. PE (74%) was the most common intervention type used, and the proportion on the order was social/family support (63%), CBT (54%), relaxation/imagery (54%), nursing intervention (52%), music therapy (14%), and other interventions (14%). Therapists included nurses (46%), doctor and oncologist (14%), psychologists (11%), and others. Finally, 21% of studies only employed the individual (i.e., one-on-one) intervention format and 68% clearly provided the information about treatments.Table 1**Characteristics of the included studies**Author & yearsAge (Mean)Subjects (n1 + n2)OutcomesPatients' selectionCancer typeCancer stageIntervention typeTherapistIntervention formatWang et al. 2000 \[[@CR39]\]18-6738 + 38Both (SDS,SAS)NonselectiveMixed-③DoctorAZhao et al. 2000 \[[@CR153]\]22-67 (52)42 + 41Both (SDS,SAS)NonselectiveMixedAdvanced① + ② + ③ + ④-A + B + CCai et al. 2001 \[[@CR144]\]26-70 (50.6)116+ 46Both (HAMD,SAS)NonselectiveMixed-⑤-A + BYang et al. 2002 \[[@CR42]\]28-65 (44.6)34 + 30Depression (HAMD)NonselectiveMixed-① + ③-BGuan et al. 2002 \[[@CR123]\]30-7144 + 44Both (SDS,SAS)NonselectiveMixed-② + ③ + ④ + ⑦OncologistBLi et al. 2002 \[[@CR76]\]32-71 (51.2)61 + 47Both (SDS,STAI)NonselectiveMixedEarly① + ② + ③ + ④ + ⑥-A + B + CLian et al. 2003 \[[@CR44]\]18-65 (46)50 + 50Both (SDS,SAS)NonselectiveHead/neck-① + ② + ④\--Wu & Wang 2003 \[[@CR148]\]30-78 (56)63 + 57Both (SDS,SAS)NonselectiveLungAdvanced① + ② + ③ + ④Doctor (training)A + B + CZhong et al. 2003 \[[@CR38]\]\>1691 + 92Both (SDS,SAS)NonselectiveMixed-②\--Lou et al. 2003 \[[@CR101]\]31-7285 + 86Depression (DSI)NonselectiveMixed-① + ② + ④NurseA + CXu 2004 \[[@CR115]\]30-70 (58)150 + 100Both (SDS,SAS)NonselectiveDigestive tract-② + ④ + ⑥ + ⑦NurseA + CWang 2004 \[[@CR93]\]36-6530 + 22Depression (SDS)NonselectiveBreast-② + ③ + ④ + ⑥NurseA + CBu et al. 2005 \[[@CR155]\]\>18 (46.5)30 + 30Anxiety (SAS)SelectiveDigestive tract-② + ③ + ④ + ⑥Nurse-Lou et al. 2005 \[[@CR164]\]24-71 (58)75 + 75Anxiety (SAS)NonselectiveMixed-① + ② + ③ + ④-A + CLiu et al. 2006 \[[@CR143]\]16-77 (51.9)58 + 53Both (SDS,STAI)NonselectiveMixed-⑤-ACheng et al. 2006 \[[@CR107]\]\>16 (65.3)15 + 15Both (HAMD,HAMA)NonselectiveMixedAdvanced① + ③ + ⑥ + ⑦\--Wang et al. 2006 \[[@CR75]\]\>18 (56.1)31 + 31Both (SDS,SAS)NonselectiveMixedAdvanced① + ④Nurse (training)/OncologistBNi et al. 2007 \[[@CR165]\]\>18 (55.4)169 + 157Anxiety (SAS)NonselectiveMixedAdvanced① + ② + ④ + ⑦DoctorA + CPang & Wang 2007 \[[@CR166]\]31-62 (59)43 + 42Anxiety (SAS)NonselectiveBreast-② + ③ + ④ + ⑥Nurse (training)A + C\*Qian & Cai 2007 \[[@CR50]\]18-6540 + 40Both (SDS,SAS)NonselectiveGynecology-① + ② + ③ + ④ + ⑥NurseA + B + CWen & Liang 2007 \[[@CR69]\]16-4073 + 63Both (SDS,STAI)NonselectiveMixed-① + ③ + ④ + ⑥-A + BKang 2007 \[[@CR128]\]40-6030 + 30Both (SDS,SAS)NonselectiveBreastAdvanced② + ⑤-A + BZheng et al. 2007 \[[@CR109]\]39-86 (58)35 + 35Both (SDS,SAS)SelectiveMixed-① + ② + ④ + ⑤Oncologist/NurseA + CDeng et al. 2007 \[[@CR110]\]32-70 (55.3)60 + 60Both (SDS,SAS)NonselectiveMixed-② + ③ + ④DoctorA + CXing 2007 \[[@CR103]\]43-75 (57.2)50 + 50Both (SDS,SAS)NonselectiveGynecology-② + ③ + ④ + ⑥-A + CWu et al. 2007 \[[@CR59]\]18-70 (48.4)40 + 40Both (SDS,SAS)NonselectiveMixedAdvanced① + ② + ③ + ④ + ⑥NurseA + B + CXu 2007 \[[@CR88]\]20-7032 + 32Both (SDS,SAS)NonselectiveGynecology-① + ③ + ④ + ⑥NurseA + B + CHan & Liu 2007 \[[@CR151]\]27-76 (59.1)30 + 30Both (SDS,SAS)NonselectiveMixed-① + ② + ④ + ⑤NurseA + BHuang et al. 2008 \[[@CR54]\]\>1640 + 40Both (SDS,SAS)NonselectiveMixed-① + ② + ③ + ④ + ⑤NurseAZheng et al. 2008 \[[@CR116]\]\>18 (58.9)38 + 39Both (SDS,SAS)NonselectiveMixed-① + ② + ③ + ④-A + CYang 2008 \[[@CR79]\]\>1640 + 40Both (SDS,SAS)NonselectiveGynecology-① + ② + ③ + ④NurseA + CHan 2008 \[[@CR160]\]33-65 (48.1)32 + 35Anxiety (SAS)NonselectiveBreast-① + ② + ④ + ⑥NurseA + CJiang et al. 2008 \[[@CR161]\]28-64 (52)52 + 52Anxiety (SAS)NonselectiveMixed-③-ALi et al. 2008 \[[@CR163]\]25-78 (53)24 + 24Anxiety (SAS)NonselectiveDigestive tract-⑥NurseAWang et al. 2008 \[[@CR169]\]\>1840 + 40Anxiety (SAS)NonselectiveDigestive tractEarly① + ② + ③ + ④ + ⑥\--Ji 2008 \[[@CR106]\]22-83 (54.2)40 + 40Depression (SDS)NonselectiveMixed-① + ② + ③ + ④Doctor/Nurse (training)A + B + CJin & Zhu 2008 \[[@CR122]\]42-65 (59)30 + 30Both (SDS,SAS)NonselectiveLung-① + ② + ③ + ④ + ⑥-A + BLi et al. 2008 \[[@CR99]\]26-73 (43.7)30 + 30Both (SDS,SAS)NonselectiveDigestive tract-② + ④ + ⑥ + ⑦NurseA + CLiu et al. 2008 \[[@CR52]\]24-70 (50)90 + 50Both (SDS,SAS)NonselectiveGynecology-① + ② + ④-A + B + CYang 2008 \[[@CR136]\]18-70 (49.7)31 + 31Both (SDS,SAS)NonselectiveBreastEarly① + ④ + ⑥ + ⑦Clinical psychologistBZhou 2008 \[[@CR100]\]26-5732 + 32Both (SDS,SAS)NonselectiveBlood-② + ③ + ④ + ⑥Nurse/Psychologist-Mao et al. 2008 \[[@CR113]\]\>16 (55.3)82 + 76Both (HAMD,HAMA)NonselectiveMixed-② + ⑥Nurse-Liu 2008 \[[@CR132]\]25-7231 + 31Both (HAMD,HAMA)NonselectiveGynecologyAdvanced② + ③-AZheng et al. 2008 \[[@CR125]\]18-70 (51.4)50 + 50Both (SDS,SAS)NonselectiveMixedAdvanced① + ② + ⑦NurseAChen et al. 2009 \[[@CR156]\]\>1833 + 32Anxiety (SAS)SelectiveDigestive tract-① + ② + ③ + ④ + ⑥ + ⑦Psychologist/Nurse (training)ALi 2009 \[[@CR89]\]30-60 (46)30 + 30Both (SDS,SAS)NonselectiveGynecology-① + ③ + ④ + ⑤\--Li et al. 2009 \[[@CR78]\]22-8478 + 78Both (SDS,SAS)NonselectiveDigestive tract-① + ② + ④Psychologist/Doctor/NurseA + B + CFu et al. 2009 \[[@CR145]\]26-60 (39.3)40 + 38Both (SDS,SAS)NonselectiveBreastAdvanced⑤-AQiu 2009 \[[@CR133]\]30-7030 + 30Both (SDS,SAS)NonselectiveLung-① + ② + ③-ASun 2009 \[[@CR134]\]\>18 (43.4)30 + 30Both (HASD)NonselectiveMixed-① + ②-AXia 2009 \[[@CR118]\]24-60 (47)28 + 28Both (SDS,SAS)SelectiveMixed-① + ② + ③ + ⑥Nurse (training)-Zhang 2009 \[[@CR139]\]18-70 (55)34 + 32Depression (SDS)SelectiveMixed-① + ② + ③-AZhou 2009 \[[@CR140]\]18-55 (45.9)30 + 30Both (SDS,SAS)SelectiveBreastEarly⑤-ALi et al. 2009 \[[@CR63]\]18-72 (40.5)61 + 59Both (SDS,SAS)NonselectiveHead/neck-① + ② + ③ + ④PsychologistBGeng et al. 2010 \[[@CR104]\]23-82124 + 123Both (SDS,SAS)NonselectiveMixed-① + ② + ③ + ④+ ⑥Researcher (training)A + CZhan & Cheng 2010 \[[@CR105]\]18-7535 + 35Both (SDS,SAS)NonselectiveLungAdvanced① + ② + ③ + ④Doctor/Nurse (training)A + B + CCheng et al. 2010 \[[@CR45]\]21-69 (47)50 + 50Both (SDS,SAS)NonselectiveHead/neck-② + ③ + ④ + ⑤Oncologist/Psychologist/NurseA + B + CLi et al. 2010 \[[@CR91]\]41-68 (52.2)50 + 50Both (SDS,SAS)NonselectiveGynecology-② + ③ + ⑥Nurse-Guan et al. 2010 \[[@CR81]\]38-70 (44)30 + 30Both (SDS,SAS)NonselectiveUrinary-② + ③ + ④Nurse-Li 2010 \[[@CR111]\]31-72 (49.7)57 + 57Both (SDS,SAS)NonselectiveMixedAdvanced④ + ⑥Doctor/NurseA + B + CZhang 2010 \[[@CR138]\]\>18 (49.7)47 + 48Both (SDS,SAS)NonselectiveBreastEarly①+④+⑦-BSu & Wang 2010 \[[@CR167]\]\>18 (52.9)41 + 46Anxiety (SAS)SelectiveDigestive tract-①+②+④+⑥Nurse (training)A + CFu et al. 2010 \[[@CR159]\]27-64 (46.5)36 + 28Anxiety (SAS)NonselectiveMixedAdvanced②+ ③+ ④+ ⑤+ ⑥-A + CWu & Zhang 2010 \[[@CR170]\]30-75 (48)40 + 39Anxiety (SAI)NonselectiveDigestive tractAdvanced① + ③ + ④ + ⑤ + ⑥Nurse-Zhou 2010 \[[@CR176]\]30-6560 + 60Anxiety (SAS)NonselectiveBreast-① + ② + ③ + ④ + ⑥Nurse-You et al. 2010 \[[@CR171]\]\>18 (48.9)33 + 29Anxiety (SAS)NonselectiveBreast-① + ②NurseARen et al. 2010 \[[@CR154]\]33-74 (54.2)40 + 37Both (SDS,SAS)NonselectiveMixed-① + ③ + ④-A + B + CXu 2010 \[[@CR40]\]27-73 (51)47 + 43Both (SDS,SAS)SelectiveMixed-① + ② + ⑥NurseAGuo et al. 2010 \[[@CR71]\]23-82 (45.4)45 + 45Both (SDS,SAS)NonselectiveMixedAdvanced① + ②Researcher (cognitive therapy training)ATang et al. 2010 \[[@CR126]\]\>18 (49.8)40 + 40Both (SDS,SAS)NonselectiveBreast-① + ② + ③ + ④NurseA + CLiu et al. 2010 \[[@CR46]\]\>16 (51.1)50 + 50Both (SDS,SAS)NonselectiveMixed-② + ⑥Nurse (training)-Shi et al. 2010 \[[@CR108]\]21-79 (54)20 + 20Depression (HAMD)SelectiveDigestive tractAdvanced④ + ⑥PsychologistA + BLiu et al. 2010 \[[@CR87]\]\>16 (57.5)37 + 35Both (SDS,SAS)NonselectiveLungEarly②+④PsychologistA + B + CWang 2010 \[[@CR90]\]\>16 (48.1)43 + 43Both (SDS,SAS)NonselectiveGynecology-① + ② + ③ + ④ + ⑥-A + BHuang et al. 2010 \[[@CR86]\]\>16 (63.6)32 + 28Both (SDS,SAS)NonselectiveLung-① + ② + ④ + ⑥\--Zhang & Yu 2011 \[[@CR94]\]21-5360 + 60Both (SDS,SAS)NonselectiveBreast-② + ③ + ④ + ⑥-A + CDu et al. 2011 \[[@CR61]\]\>16 (42.7)28 + 30Both (SDS,SAS)NonselectiveBreast-①NurseALi et al. 2011 \[[@CR149]\]\>18 (47)20 + 20Both (SDS,SAS)SelectiveGynecology-① + ② + ③ + ④ + ⑥-AZhou et al. 2011 \[[@CR180]\]25-65 (45)54 + 51Depression (SDS)NonselectiveBreast-⑤-ALiu 2011 \[[@CR131]\]23-6530 + 30Both (SDS,SAS)SelectiveGynecology-①+③+⑤+⑦-A + CShen et al. 2011 \[[@CR64]\]39-71 (58.1)37 + 38Both (SDS,SAS)NonselectiveDigestive tract-②+⑥NurseAZhu et al. 2011 \[[@CR65]\]\>60 (74)50 + 48Depression (SDS)NonselectiveDigestive tract-② + ③ + ④ + ⑥NurseA + BMeng et al. 2011 \[[@CR95]\]34-74 (57)46 + 41Both (SDS,SAS)NonselectiveMixedAdvanced② + ③ + ⑥ + ⑦Nurse-Dai et al. 2011 \[[@CR157]\]23-78 (57.9)66 + 68Anxiety (SAI)NonselectiveMixed-① + ② + ③ + ④ + ⑥Oncologist/Psychologist/Nurse/NutritionistBJiao et al. 2011 \[[@CR162]\]40-66 (55.8)34 + 34Anxiety (SAS)NonselectiveGynecologyAdvanced① + ② + ③ + ④ + ⑥Nurse (training)A + CYe 2011 \[[@CR56]\]24-65 (43.5)20 + 20Both (SDS,SAS)SelectiveGynecology-①+③-ALi 2011 \[[@CR130]\]18-8037 + 32Depression (SDS)NonselectiveDigestive tractEarly① + ② + ③ + ④ + ⑤ + ⑥ + ⑦-A + B + CLiu et al. 2011 \[[@CR41]\]30-5050 + 50Depression (SDS)NonselectiveMixed-① + ② + ④Medical staffA + BWang et al. 2011 \[[@CR37]\]\>16 (59.03)30 + 31Both (HAMD,HAMA)NonselectiveMixed-⑤PsychologistBCao2011 \[[@CR173]\]\>1830 + 30Anxiety (SAS)NonselectiveBreast-③Nurse (psychological/music training)AZhao & Zhang 2011 \[[@CR174]\]18-7021 + 20Anxiety (SAS)SelectiveGynecology-① + ② + ③ + ④ + ⑥NurseA + CCao & Li 2011 \[[@CR67]\]\>1655 + 53Both (SDS,SAS)NonselectiveMixed-③-A + B + CHuang et al. 2011 \[[@CR152]\]33-71140 + 139Depression (SDS)NonselectiveMixed-① + ② + ⑥Nurse (training)A + B + CHu & Yan 2011 \[[@CR62]\]30-52 (45)32 + 32Both (SDS,SAS)NonselectiveMixed-① + ④Psychologist/Oncologist/Nurse (training)BGuan & Jin 2011 \[[@CR120]\]18-75 (66)78 + 78Both (SDS,SAS)NonselectiveMixedAdvanced① + ② + ③ + ④ + ⑥ + ⑦-A + CLv et al. 2011 \[[@CR77]\]25-6538 + 38Both (SDS,SAS)NonselectiveGynecologyEarly① + ② + ③ + ④NurseA + BLi et al. 2011 \[[@CR182]\]25-65 (45)54 + 51Anxiety (SAI)NonselectiveBreast-⑤-ACao & Jiang 2011 \[[@CR177]\]\>18 (51.5)42 + 42Anxiety (SAS)NonselectiveLung-② + ③ + ④ + ⑥NurseA + B + CHuang2011 \[[@CR102]\]\>16 (54.23)40 + 40Depression (HAMD)SelectiveMixed-① + ② + ③ + ⑥-A + BZheng et al. 2011 \[[@CR141]\]21-81 (54)102 + 111Both (SDS,SAS)NonselectiveMixed-②+④+⑥NurseA + B + CWu & Dong 2011 \[[@CR47]\]48-78 (63.3)33 + 33Both (HAMD,HAMA)SelectiveMixed-② + ③ + ④ + ⑤-A + CZheng et al. 2012 \[[@CR150]\]19-70 (52.6)28 + 28Depression (SDS)SelectiveMixed-① + ② + ④DoctorA + CWang & Xiao 2012 \[[@CR124]\]\>18 (57.5)42 + 42Both (SDS,SAS)NonselectiveMixed-① + ② + ⑥PsychologistAWei 2012 \[[@CR135]\]\>18 (48.1)30 + 30Both (SDS,SAS)NonselectiveBreast-① + ② + ③ + ⑥-A + BFeng 2012 \[[@CR55]\]35-65 (50.9)45 + 45Both (SDS,SAS)NonselectiveBreast-① + ② + ⑦-AYang et al. 2012 \[[@CR73]\]48-8120 + 20Both (SDS,SAS)NonselectiveBreastAdvanced① + ② + ③ + ④PsychologistA + B + CZhao et al. 2012 \[[@CR84]\]18-75 (57.2)103 + 102Both (SDS,SAS)NonselectiveMixed-① + ② + ⑦Doctor-Gu 2012 \[[@CR121]\]47-74 (64.6)52 + 48Both (SDS,SAS)NonselectiveLung-④ + ⑥ + ⑦NurseA + CZheng2012 \[[@CR58]\]45-72 (51.6)30 + 30Both (HAMD,HAMA)SelectiveMixed-② + ③ + ⑥\--Yang2012 \[[@CR66]\]59-76 (65.4)23 + 20Depression (SDS)SelectiveDigestive tract-②+④+⑥NurseA + CSun et al. 2012 \[[@CR60]\]21-78 (49.4)89 + 89Both (SDS,SAS)NonselectiveMixed-② + ③ + ④ + ⑥Psychologist/NurseA + B + CLiu et al. 2012 \[[@CR98]\]\>18 (48.6)30 + 30Both (SDS,SAS)NonselectiveDigestive tract-③ + ④+ ⑦-A + CYang et al. 2012 \[[@CR70]\]20-70 (58.4)48 + 40Both (SDS,SAS)NonselectiveMixedAdvanced② + ④ + ⑥Nurse-Li 2012 \[[@CR129]\]34-36 (41.7)51 + 51Both (CES-D,SAI)NonselectiveMixed-② + ⑥NurseAZhu & Hu 2012 \[[@CR68]\]23-76 (44.3)45 + 46Both (SDS,SAS)NonselectiveGynecology-②+④+⑥Nurse (training)A + B + CLiu 2012 \[[@CR48]\]45-74 (62.3)40 + 40Depression (HAMD)NonselectiveMixed-① + ② + ④ + ⑥NurseA + CShi et al. 2012 \[[@CR92]\]21-65 (53.5)74 + 74Both (SDS,SAS)NonselectiveGynecology-② + ③ + ⑥-AJia2012 \[[@CR127]\]43-77 (55.8)35 + 32Both (HAMD,HAMA)NonselectiveHead/neck-② + ③ + ④ + ⑥ + ⑦-A + CZhang 2012 \[[@CR97]\]34-71 (63.5)45 + 45Both (SDS,SAS)NonselectiveMixedAdvanced② + ⑥\--Chen 2012 \[[@CR51]\]18-79 (51)43 + 44Both (SDS,SAS)NonselectiveGynecology-① + ② + ③ + ⑥-A + CLi et al. 2012 \[[@CR146]\]\>18 (57.2)30 + 30Both (HAMD,HAMA)NonselectiveHead/neck-① + ② + ③ + ⑦Doctor (training)/PsychologistAYang & Wang 2012 \[[@CR83]\]29-6930 + 30Both (HAMD,HAMA)NonselectiveMixedAdvanced② + ③ + ④ + ⑤ + ⑥-A + CJiang et al. 2012 \[[@CR49]\]\>1644 + 45Depression (SDS)NonselectiveHead/neck-① + ② + ③NurseAFan & Pan 2012 \[[@CR158]\]30-4819 + 19Anxiety (SAS)SelectiveGynecology-② + ④ + ⑥ + ⑦-A + CLi et al. 2012 \[[@CR72]\]24.5-7050 + 50Both (SDS,SAS)NonselectiveBreast-② + ③ + ④NurseA + B + C\*Han et al. 2012 \[[@CR85]\]18-91 (74)43 + 42Both (SDS,SAS)NonselectiveMixed-② + ③ + ④ + ⑥Doctor/Nurse (training)A + CZheng et al. 2012 \[[@CR175]\]25-69 (46.5)30 + 30Anxiety (SAS)NonselectiveMixed-① + ② + ③ + ④ + ⑥-A + CYuan & Wu 2013 \[[@CR147]\]50-70 (63)78 + 78Both (SDS,SAS)NonselectiveMixedAdvanced① + ⑥-A + CZhu et al. 2013 \[[@CR36]\]43-7825 + 25Both (SDS,SAS)NonselectiveLung-⑦\--Du 2013 \[[@CR74]\]24-76 (46.3)36 + 36Both (SDS,SAS)NonselectiveGynecology-① + ② + ⑥Nurse/Community DoctorA + B + C\*Mu et al. 2012 \[[@CR178]\]32-70 (56.2)60 + 60Anxiety (SAS)NonselectiveUrinary-① + ② + ③ + ④ + ⑥NurseA + B + CLiu & Gan 2013 \[[@CR43]\]18-67 (49.3)101 + 90Both (SDS,STAI)NonselectiveMixed-⑤-AZhang 2013 \[[@CR96]\]32-7372 + 72Both (SDS,SAS)NonselectiveMixedAdvanced① + ② + ③ + ④ + ⑥-A + CZhang et al. 2013 \[[@CR142]\]32-72 (54)33 + 35Both (SDS,SAS)NonselectiveMixed-② + ④ + ⑦Doctor (training)BGuo et al. 2013 \[[@CR179]\]\>18 (47)89 + 89Both (SDS,SAS)NonselectiveMixed-① + ②+ ⑦Clinician/Nurse/Radiation therapist (training)BLiu 2013 \[[@CR119]\]31-65 (53.3)45 + 45Both (SDS,SAS)SelectiveMixed-③ + ⑥NurseAZhai et al. 2013 \[[@CR82]\]47-62 (52)39 + 39Both (SDS,SAS)NonselectiveHead/neck-② + ③ + ④ + ⑥NurseA + CCi et al. 2013 \[[@CR117]\]25-6530 + 30Both (SDS,SAS)NonselectiveMixed-② + ⑥NurseA + CLiu 2013 \[[@CR112]\]46-71 (51.4)59 + 59Both (SDS,SAS)SelectiveMixed-② + ④-A + CLiu et al. 2013 \[[@CR57]\]35-76 (53)29 + 29Both (SDS,SAS)NonselectiveBone metastatic-① + ② + ③ + ④+ ⑥Nurse-Qiu et al. 2013 \[[@CR181]\]31-64 (50.6)29 + 25Both (HAMD,SAS)SelectiveBreastEarly①Psychiatrist (CBT and group therapy training)BMao et al. 2013 \[[@CR80]\]\>16 (58.2)100 + 100Both (SDS,SAS)NonselectiveMixed-① + ② + ③ + ④ + ⑥PsychologistA + CZhang 2013 \[[@CR114]\]18-70 (46)53 + 53Both (SDS,SAS)NonselectiveGynecology-① + ② + ③ + ④ + ⑥NurseA + CYu 2013 \[[@CR137]\]\>1879 + 41Both (SDS,SAS)NonselectiveHead/neck-③ + ④ + ⑥DoctorA + B + CWang 2013 \[[@CR53]\]21-70 (45)50 + 50Both (SDS,SAS)NonselectiveGynecology-① + ②+ ④NurseA + CTian et al. 2013 \[[@CR168]\]\>18 (61.1)98 + 97Anxiety (SAS)NonselectiveMixed-② + ④ + ⑤ + ⑥NurseA + CYu 2013 \[[@CR172]\]33-61 (41.9)83 + 83Anxiety (SAS)NonselectiveBreast-② + ④ + ⑥-A + C\**Abbreviations*: *n1* participants in experimental group, *n2* participants in control group, *SDS* Self-rating Depression Scale, *SAS* Self-rating Anxiety Scale, *HAMD* Hamilton Depression Rating Scale, *HAMA* Hamilton Anxiety Rating Scale, *STAI* State-Trait Anxiety Inventory, *DSI* Depression Screening Instrument, *CES-D* Center for Epidemiologic Studies Depression Scale, *SAI* State Anxiety Inventory, *HASD* Hospital Anxiety and Depression Scale, *①* cognitive-behavioral interventions, *②* patients education, *③* relaxation/imagery, *④* social/family support, *⑤* music therapy, *⑥* nursing intervention, *⑦* other interventions, *A* individual, *B* Group, *C* Family, *C\** Couple, *−* no report.

Risk of bias assessment {#Sec16}
-----------------------

Ratings of study quality for each criteria of the modified Jadad were presented in Table [2](#Tab2){ref-type="table"}. As shown in Table [2](#Tab2){ref-type="table"}, higher scores reflected the better study quality, and the average scores of all studies were above 2 (mean: 2.68). Nineteen studies were judged to have low quality for random sampling or withdrawals/dropouts or inclusion/exclusion criteria or the statistical analysis and twenty-seven of high quality. Other studies were rated as medium quality.Table 2**Assessment of study quality**StudiesQuality Indicators from the modified Jadad scaleTotal scoreABCDEWang et al. 2000 \[[@CR39]\]100001Zhao et al. 2000 \[[@CR153]\]100113Cai et al. 2001 \[[@CR144]\]100012Yang et al. 2002 \[[@CR42]\]110103Guan et al. 2002 \[[@CR123]\]100012Li et al. 2002 \[[@CR76]\]1−10112Lian et al. 2003 \[[@CR44]\]100113Wu & Wang 2003 \[[@CR148]\]110114Zhong et al. 2003 \[[@CR38]\]100012Lou et al. 2003 \[[@CR101]\]1−10112Xu 2004 \[[@CR115]\]100012Wang 2004 \[[@CR93]\]100001Bu et al. 2005 \[[@CR155]\]111115Lou et al. 2005 \[[@CR164]\]1−10011Liu et al. 2006 \[[@CR143]\]101013Cheng et al. 2006 \[[@CR107]\]100001Wang et al. 2006 \[[@CR75]\]101103Ni et al. 2007 \[[@CR165]\]100012Pang & Wang 2007 \[[@CR166]\]100012Qian & Cai 2007 \[[@CR50]\]110114Wen & Liang 2007 \[[@CR69]\]100102Kang 2007 \[[@CR128]\]100001Zheng et al. 2007 \[[@CR109]\]100113Deng et al. 2007 \[[@CR110]\]100113Xing 2007 \[[@CR103]\]100113Wu et al. 2007 \[[@CR59]\]100113Xu 2007 \[[@CR88]\]100102Han & Liu 2007 \[[@CR151]\]1−10011Huang et al. 2008 \[[@CR54]\]100102Zheng et al. 2008 \[[@CR116]\]100113Yang 2008 \[[@CR79]\]110103Han 2008 \[[@CR160]\]100012Jiang et al. 2008 \[[@CR161]\]100113Li et al. 2008 \[[@CR163]\]100012Wang et al. 2008 \[[@CR169]\]100113Ji 2008 \[[@CR106]\]1−10011Jin & Zhu 2008 \[[@CR122]\]100001Li et al. 2008 \[[@CR99]\]100012Liu et al. 2008 \[[@CR52]\]110013Yang 2008 \[[@CR136]\]110114Zhou 2008 \[[@CR100]\]100001Mao et al. 2008 \[[@CR113]\]110013Liu 2008 \[[@CR132]\]110114Zheng et al. 2008 \[[@CR125]\]100113Chen et al. 2009 \[[@CR156]\]100012Li 2009 \[[@CR89]\]100012Li et al. 2009 \[[@CR78]\]100113Fu et al. 2009 \[[@CR145]\]1−10011Qiu 2009 \[[@CR133]\]100113Sun 2009 \[[@CR134]\]100113Xia 2009 \[[@CR118]\]1−10112Zhang 2009 \[[@CR139]\]111115Zhou 2009 \[[@CR140]\]100113Li et al. 2009 \[[@CR63]\]1−10011Geng et al. 2010 \[[@CR104]\]101114Zhan & Cheng 2010 \[[@CR105]\]110114Cheng et al. 2010 \[[@CR45]\]100113Li et al. 2010 \[[@CR91]\]110013Guan et al. 2010 \[[@CR81]\]100113Li 2010 \[[@CR111]\]1−10112Zhang 2010 \[[@CR138]\]111115Su & Wang 2010 \[[@CR167]\]111115Fu et al. 2010 \[[@CR159]\]100012Wu & Zhang 2010 \[[@CR170]\]100012Zhou 2010 \[[@CR176]\]1−10011You et al. 2010 \[[@CR171]\]100113Ren et al. 2010 \[[@CR154]\]110114Xu 2010 \[[@CR40]\]100113Guo et al. 2010 \[[@CR71]\]101114Tang et al. 2010 \[[@CR126]\]1−10112Liu et al. 2010 \[[@CR46]\]100012Shi et al. 2010 \[[@CR108]\]100113Liu et al. 2010 \[[@CR87]\]110114Wang 2010 \[[@CR90]\]1−10112Huang et al. 2010 \[[@CR86]\]100012Zhang & Yu 2011 \[[@CR94]\]1−10000Du et al. 2011 \[[@CR61]\]100113Li et al. 2011 \[[@CR149]\]110114Zhou et al. 2011 \[[@CR180]\]111115Liu 2011 \[[@CR131]\]100113Shen et al. 2011 \[[@CR64]\]101114Zhu et al. 2011 \[[@CR65]\]1−10112Meng et al. 2011 \[[@CR95]\]100012Dai et al. 2011 \[[@CR157]\]1−10112Jiao et al. 2011 \[[@CR162]\]110013Ye 2011 \[[@CR56]\]100012Li2011 \[[@CR130]\]110114Liu et al. 2011 \[[@CR41]\]100113Wang et al. 2011 \[[@CR37]\]1−11102Cao 2011 \[[@CR173]\]1−10112Zhao & Zhang 2011 \[[@CR174]\]100113Cao & Li 2011 \[[@CR67]\]100113Huang et al. 2011 \[[@CR152]\]100012Hu & Yan 2011 \[[@CR62]\]111115Guan & Jin 2011 \[[@CR120]\]110114Lv et al. 2011 \[[@CR77]\]1−10011Li et al. 2011 \[[@CR182]\]111115Cao & Jiang 2011 \[[@CR177]\]100113Huang 2011 \[[@CR102]\]100113Zheng et al. 2011 \[[@CR141]\]110114Wu & Dong 2011 \[[@CR47]\]100113Zheng et al. 2012 \[[@CR150]\]100102Wang & Xiao 2012 \[[@CR124]\]100113Wei 2012 \[[@CR135]\]100102Feng 2012 \[[@CR55]\]1−10011Yang et al. 2012 \[[@CR73]\]100113Zhao et al. 2012 \[[@CR84]\]100113Gu 2012 \[[@CR121]\]100113Zheng 2012 \[[@CR58]\]1−10112Yang 2012 \[[@CR66]\]100113Sun et al. 2012 \[[@CR60]\]100113Liu et al. 2012 \[[@CR98]\]100113Yang et al. 2012 \[[@CR70]\]100113Li 2012 \[[@CR129]\]101114Zhu & Hu 2012 \[[@CR68]\]110114Liu 2012 \[[@CR48]\]110114Shi et al. 2012 \[[@CR92]\]110013Jia 2012 \[[@CR127]\]100102Zhang 2012 \[[@CR97]\]100012Chen 2012 \[[@CR51]\]100113Li et al. 2012 \[[@CR146]\]110013Yang & Wang 2012 \[[@CR83]\]100113Jiang et al. 2012 \[[@CR49]\]1−10112Fan & Pan 2012 \[[@CR158]\]1−10011Li et al. 2012 \[[@CR72]\]100113Han et al. 2012 \[[@CR85]\]100113Zheng et al. 2012 \[[@CR175]\]100012Yuan & Wu 2013 \[[@CR147]\]100113Zhu et al. 2013 \[[@CR36]\]1−10112Du 2013 \[[@CR74]\]100001Mu et al. 2012 \[[@CR178]\]100012Liu & Gan 2013 \[[@CR43]\]1−10112Zhang 2013 \[[@CR96]\]100113Zhang et al. 2013 \[[@CR142]\]110013Guo et al. 2013 \[[@CR179]\]111115Liu 2013 \[[@CR119]\]100012Zhai et al. 2013 \[[@CR82]\]100113Ci et al. 2013 \[[@CR117]\]100012Liu 2013 \[[@CR112]\]100001Liu et al. 2013 \[[@CR57]\]100113Qiu et al. 2013 \[[@CR181]\]111115Mao et al. 2013 \[[@CR80]\]100113Zhang 2013 \[[@CR114]\]100113Yu 2013 \[[@CR137]\]100113Wang 2013 \[[@CR53]\]100012Tian et al. 2013 \[[@CR168]\]101114Yu 2013 \[[@CR172]\]1−10011Note: The modified Jadad scale is an eight-item scale. Considering the characteristic and effect of psychological interventions, blinding (2 points) and adverse effects (1 point) were excluded.*Abbreviations*: A represents "Was the study described as randomized?" (1: Yes; 0: No); B represents "Was the method of randomization appropriate?" (1: Yes; 0: Not described; −1: No); C represents "Was there a description of withdrawals and dropouts?" (1: Yes; 0: No); D represents "Was there a clear description of the inclusion/exclusion criteria?" (1: Yes; 0: No); E represents "Was the methods of statistical analysis described?" (1: Yes; 0: No).

Effects of psychological interventions on depression and anxiety in cancer patients {#Sec17}
-----------------------------------------------------------------------------------

A pooled random-effects meta-analysis was conducted using data from 147 studies, which estimated the post-test effects of psychological interventions on depression and anxiety compared with care-as-usual control group. This meta-analysis included data for 7,181 patients in the experimental group, and 6,858 patients in the control group. As shown in Figures [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}, the random effects model showed an overall effect size of SMD = 1.199 (95% CI = 1.095-1.303; p \< 0.001) for depression in 122 studies, and a large effect size was also observed (SMD = 1.298, 95% CI = 1.187-1.408; p \< 0.001) for anxiety in 131 studies. However, the heterogeneity analysis of the effect sizes of depression (Q = 787.21, p \< 0.001; I^2^ = 84.6%) and anxiety (Q = 1016.74, p \< 0.001; I^2^ = 87.2%) indicated that there was a relatively high amount of heterogeneity in our meta-analysis.Figure 3**Forest plot of the effects of psychological interventions on depression in cancer patients.** It shows a pooled SMD of 1.199 (95% CI = 1.095-1.303; p \< 0.001), indicating that psychological interventions could alleviate depression among Chinese adults with cancer. Abbreviations: SMD, standardized mean difference.Figure 4**Forest plot of the effects of psychological interventions on anxiety in cancer patients.** It shows a pooled SMD of 1.298 (95% CI = 1.187-1.408; p \< 0.001), indicating that psychological interventions could alleviate anxiety among Chinese adults with cancer. Abbreviations: SMD, standardized mean difference.

Moderator analysis {#Sec18}
------------------
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Publication bias {#Sec19}
----------------

Visual inspection of the funnel plot indicated some publication bias, and the Begg's test and Egger's test further suggested the publication bias in depression (Begg's test, Z = 4.16, P \< 0.001; Egger's test, Coef = 3.659, P \< 0.001) and anxiety (Begg's test, Z = 4.99, P \< 0.001; Egger's test, Coef = 4.469, P \< 0.001) in our meta-analysis.

Cumulative meta-analysis {#Sec20}
------------------------

Cumulative meta-analysis (Figure [5](#Fig5){ref-type="fig"}) indicated that the protective effects of psychological interventions on depression became evident in 2000. Since 2012, the overall effect size (SMD) has remained relatively stable (range: 1.15 - 1.21), and subsequent studies published in 2013 hardly changed the overall effect size. The protective effects of psychological interventions on anxiety became evident in 2001 (Figure [6](#Fig6){ref-type="fig"}). Sufficient body of RCTs had accumulated by 2003 to determine a reliable and consistent point estimate (fluctuated around 1.3), and resulted in a narrowing of the 95% CI.Figure 5**Cumulative meta-analysis of randomized trials comparing psychological interventions with control: depression.** Abbreviations: SMD, standardized mean difference.Figure 6**Cumulative meta-analysis of randomized trials comparing psychological interventions with control: anxiety.** Abbreviations: SMD, standardized mean difference.

Discussion {#Sec21}
==========

At the beginning of discussion, we would evaluate the heterogeneity and study quality in the present meta-analysis. First, we performed strict inclusion criteria, random effects models and moderator analysis to control and reduce the heterogeneity. However, the heterogeneity was still relatively high, and the conclusion should be considered with some caution. Second, the modified Jadad scale was used to assess the study quality. Although most of the included studies (87%) had medium-quality or high-quality, studies in our meta-analysis had the high bias of the inappropriate methods of randomization (79%) and the lack of description of withdrawals/dropouts (88%). Quality assessment indicated these methodological weaknesses, which could weaken the internal validity.

In the present meta-analysis, we analyzed the effects of psychological interventions on depression and anxiety among Chinese adults with cancer. To our knowledge, this is the largest and the most comprehensive meta-analysis studying the effects of psychological interventions on psychological distress in Chinese adults with cancer, and psychological interventions were proven effective to relieve cancer patients' depression (SMD = 1.199, 95% CI = 1.095-1.303) and anxiety (SMD = 1.298, 95% CI = 1.187-1.408) in our meta-analysis. Although the research of psychological interventions in cancer patients is quite common, the large and comprehensive meta-analysis conducted by foreign researchers usually excluded Chinese studies because they were published in a foreign language \[[@CR20]\]. Some Chinese meta-analysis in this field only included only a small number of studies (n = 11) \[[@CR183], [@CR184]\], which did not accurately reflect the current research of psychological interventions in Chinese cancer patients. On the other hand, the results of cumulative meta-analysis showed that the protective effects of psychological interventions on depression/anxiety were evident from 2000--2001 onwards. Subsequent included studies have only tried to increase the precision and reliability of effectiveness of psychological interventions in Chinese adults with cancer, and the overall effect size was both substantial and unlikely to be changed by the further RCTs evidence.

We also compared our results with three other relatively comprehensive meta-analyses exploring the effects of psychological interventions on depression/anxiety in cancer patients: (1) the study of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer conducted by Faller (Depression: n = 72, Cohen's d = 0.33, 95% CI = 0.25-0.41; Anxiety: n = 74, Cohen's d = 0.38, 95% CI = 0.29-0.46) \[[@CR20]\]; (2) the research of the effects of psychological interventions on anxiety/depression in cancer patients reported by Sheard (Depression: n = 20, effect size = 0.36, 95% CI = 0.06-0.66; Anxiety: n = 19, effect size = 0.42, 95% CI = 0.08-0.74) \[[@CR19]\]; (3) the review of psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients conducted by Galway (Depression: n = 6, SMD = 0.12, 95% CI = −0.07-0.31; Anxiety: n = 4, SMD = 0.05, 95% CI = −0.13-0.22) \[[@CR17]\]. There might be several reasons for the different effect sizes. The first explanation might be that nearly half of the included studies in our meta-analysis (48%) adopted the psychosocial interventions targeting at both patient and their family members (this percentage in Faller's study \[[@CR20]\] is 4%). Psychosocial interventions involving family members have been proven to be beneficial for depression of chronic illness patients, including cancer patients \[[@CR185]\]. Moreover, family is the bedrock of Chinese society, and the care and concern of family members are of great importance for cancer patients. Second, most of the included studies of these meta-analyses are from developed countries and have lower prevalence of mental health problems as compared to developing countries like China \[[@CR186]\], and our previous studies also found that the prevalence of depression/anxiety was very high among Chinese cancer patients \[[@CR10], [@CR187]\]. Psychological interventions on depression and anxiety were generally highly effective when psychological distress was at a high level at baseline \[[@CR188]\]. Third, with the exception of one study of outpatients in non-hospital setting \[[@CR74]\], all of the patients in our study were inpatients who had adequate time and appropriate locations to receive psychological interventions (this percentage of inpatients in Faller's study \[[@CR20]\] is 16%), thus with a reduced risk for drop-out. Studies on the issues of compliance/dropout claimed that drop-out rate was an important indicator of therapeutic effectiveness \[[@CR189]\]. Therefore, the large effect size in our study may be due to the reduced risk of drop-out. The last explanation might be that these three meta-analyses mainly included breast cancer patients (Faller's study: 39% \[[@CR20]\]; Galway's study: 30% \[[@CR17]\]). Our meta-analysis found that the effect of psychological interventions on depression/anxiety was the smallest among breast cancer patients (this percentage in our study was 15%), and this might also inflate the overall effect sizes.

In the present meta-analysis, no moderating effect was found for intervention type (continuous variable) in univariate and multiple meta-regressions analysis. Similar to the results of our meta-analysis, most of psychological interventions in other comprehensive meta-analyses were integrative \[[@CR17], [@CR19], [@CR20]\], so it could be difficult to compare the effects of different psychotherapies. However, significant medium-to-large effects were observed for the meta-analyses focusing on the separate psychological interventions (e.g., mindfulness-based therapy, relaxation/imagery, and CBT) \[[@CR21]--[@CR23]\], indicating that the quality and content of psychological interventions could be more important for cancer patients than the total types of included interventions.

Through the subgroups analysis of moderator variables (categorical variable), significant moderator effects were found for cancer type, patients' selection, intervention format and questionnaires employed. The order of the effects of psychological interventions on depression/anxiety was lung cancer, head/neck cancer, digestive tract/gynecological cancer and breast cancer among different types of cancer. The epidemiological features and the psychosocial problems of the specific types of cancer might be the leading cause of this result. Lung cancer is the leading cause of cancer death in both men and women in China and the world \[[@CR24], [@CR190]\], and lung cancer patients were at higher risk for psychosocial problems (e.g., stigma and depression) \[[@CR191], [@CR192]\]. For example, lung cancer patients experienced the greatest amount of psychological distress among 14 types of cancer \[[@CR193]\]. Head/neck and gynecological cancer patients also experienced the unique stress and psychological problems. Patients had to face stigma, functional impairment and disfigurement caused by the cancer and/or the treatment \[[@CR191], [@CR194]\], and gynecological cancer patients had problems including stigma, self-image, female fertility, and changes in sexual function \[[@CR187], [@CR191]\]. However, in China, the death rate of breast cancer was at a medium or low level (ranked as the fifth following lung cancer and digestive tract cancer) \[[@CR190]\], and survival rates have increased to the extent that more than 70% now survived 5 years after diagnosis in urban areas \[[@CR195]\]. In a large cancer cohort, higher rates of mixed anxiety/depression symptoms were found in patients with digestive tract, head/neck, and lung cancers, while lower rates were observed in those with breast cancers \[[@CR196]\]. As a result, compared with breast cancer patients, other types of cancer patients might have a higher level of psychological distress, and the effects of psychological interventions on depression/anxiety were larger in patients with lung, head/neck, digestive tract, and gynecological cancers \[[@CR188]\].

Effect sizes of patients with clear signs of depression/anxiety were significantly larger for depression, and individually based interventions were more effective for anxiety than those delivered in other formats. Psychological interventions appeared to be more useful for patients with increased psychological distress, which was similar to the findings of other meta-analyses in this field \[[@CR17], [@CR19], [@CR20]\], indicating that compared with non-screened patients, patients with clear signs of psychological distress could benefit more from psychological interventions, and the effects of interventions targeted at those at risk of psychological distress would be much larger. Additionally, individual interventions appeared to be more effective for anxiety in our meta-analysis, indicating that individual therapy could be more suitable for anxiety among cancer patients. Individual interventions were better suited to handle particular, individual and internal problems \[[@CR197]\], and to some extent, anxiety is a normal and individual reaction when a person is faced with different stressors, including cancer \[[@CR10], [@CR187]\]. Therefore, individual interventions might be more helpful to deal with the anxiety caused by different types of cancer. However, some studies reported the conflicting results \[[@CR19], [@CR21], [@CR198]\], and more studies are needed to confirm whether the effects of psychotherapy on psychological distress are affected by intervention format. Finally, in addition to considering these moderator effects, it is also important to evaluate the influence of different kinds of questionnaires employed on the outcomes of psychological interventions among cancer patients.

Implication {#Sec22}
-----------

There are several theoretical and practical implications for our meta-analysis. In theory, although cultural traditions, life experience, social economy and ideology were different between China and Western countries, the present meta-analysis suggested that the psychological interventions (or psychotherapies) widely used in Western countries are also suitable and even more efficacious in Eastern culture context. In practice, first, some developed countries, such as United States and Australia, have developed several clinical practice guidelines for the psychotherapy and supportive care of cancer patients \[[@CR199]\], but the corresponding management systems and processes are still not available in China. Therefore, the Chinese government and Chinese medical settings should set up an adequate institutional and organizational system to provide routine use of psychological interventions in cancer patients; second, when interventions are performed, quality and content of interventions might be more important for cancer patients than the total types of included interventions, and further studies should be conducted to explore whether psychological interventions involving family members will be more effective for depression/anxiety in cancer patients; third, our findings also provided guidance in developing optimal methods and appropriate standards of psychological interventions in clinical practice. For example, oncologists and physicians should pay more attention to detecting depression/anxiety of specific types of cancer (e.g., lung cancer), and necessary and timely psychological interventions should be taken to alleviate depression/anxiety in these cancer patients. Moreover, psychotherapeutic programs should screen and preselect patients with clear signs of depression/anxiety, so that the limited clinical resources in China could be appropriately allocated and produce maximal cost-effectiveness and clinical benefits.

Limitation {#Sec23}
----------

The present meta-analysis had several limitations. First, our meta-analysis did not provide enough information and number of studies regarding other potential moderating factors, such as gender, income, intervention sessions and duration, and metastasis. Second, although we employed moderator analysis to explore potential sources of heterogeneity, the moderator analysis could not reduce I^2^ to 75% or less in many cases. This may be mainly because interventions in our meta-analysis varied greatly with respect to intervention type and professionalism of therapists, and other important moderating factors. Third, most of the included studies were conducted using self-rating questionnaires (e.g., SAS and SDS) to measure depression and anxiety. Therefore, depression and anxiety in our meta-analysis more often referred to the depressive symptom and anxiety symptom. Fourth, because follow-up results after post-test were not reported, it is not confirmed whether there were long term effects. Fifth, unpublished researches were not included in our meta-analysis, and unpublished outcomes were often insignificant, which might inflate the effect sizes in the presented study. Finally, the high risk of publication bias is another (and perhaps the most important) limitation. This might be mainly because unlike some foreign medical journals that require registration of a trial before it commences, the systems related to registries have not yet been established in China. Thus, attempts to identify unpublished studies are very difficult.

Conclusions {#Sec24}
===========

Although there are some clear limitations (heterogeneity and publication bias) in this study, a tentative and preliminary conclusion can be reached, that psychological interventions of depression and anxiety are effective for Chinese cancer patients. In studies that included lung cancer, preselected patients with clear signs of depression/anxiety, adopted individual intervention and used STAI, the effect sizes are larger. The findings support that an adequate system should be set up to provide routine psychological interventions for cancer patients in Chinese medical settings.
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